As of 2026-09-25, the Relative Valuation of Cogent Biosciences Inc (COGT) is (69.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.43 USD, the upside of Cogent Biosciences Inc based on Relative Valuation is -321.6%.
The range of the Relative Valuation is (66.44) - (67.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.1x - 40.1x | 35.1x |
| Forward P/E multiples | 25.2x - 30.8x | 28.0x |
| Fair Price | (66.44) - (67.99) | (69.64) |
| Upside | -311.4% - -316.3% | -321.6% |
| Date | P/E |
| 2026-09-21 | -14.50 |
| 2026-09-18 | -14.27 |
| 2026-09-17 | -15.04 |
| 2026-09-16 | -14.74 |
| 2026-09-15 | -14.83 |
| 2026-09-14 | -15.14 |
| 2026-09-11 | -15.14 |
| 2026-09-10 | -15.44 |
| 2026-09-09 | -15.48 |
| 2026-09-08 | -15.98 |
| 2026-09-04 | -15.75 |
| 2026-09-03 | -15.83 |
| 2026-09-02 | -15.66 |
| 2026-09-01 | -15.71 |
| 2026-08-31 | -15.86 |
| 2026-08-28 | -15.71 |
| 2026-08-27 | -16.80 |
| 2026-08-26 | -16.63 |
| 2026-08-25 | -16.67 |
| 2026-08-24 | -16.41 |
| 2026-08-21 | -16.64 |
| 2026-08-20 | -16.00 |
| 2026-08-19 | -16.69 |
| 2026-08-18 | -16.94 |
| 2026-08-17 | -17.16 |
| 2026-08-14 | -17.18 |
| 2026-08-13 | -16.90 |
| 2026-08-12 | -17.66 |
| 2026-08-11 | -17.53 |
| 2026-08-10 | -18.81 |
| 2026-08-07 | -19.20 |
| 2026-08-06 | -18.94 |
| 2026-08-05 | -19.15 |
| 2026-08-04 | -19.41 |
| 2026-08-03 | -17.60 |
| 2026-07-31 | -17.64 |
| 2026-07-30 | -18.74 |
| 2026-07-29 | -17.93 |
| 2026-07-28 | -18.42 |
| 2026-07-27 | -18.32 |
| 2026-07-24 | -18.01 |
| 2026-07-23 | -18.23 |
| 2026-07-22 | -17.91 |
| 2026-07-21 | -17.96 |
| 2026-07-20 | -17.35 |
| 2026-07-17 | -17.70 |
| 2026-07-16 | -17.19 |
| 2026-07-15 | -17.80 |
| 2026-07-14 | -17.45 |
| 2026-07-13 | -16.97 |